维生素D水平与新型冠状病毒肺炎相关性的研究进展
Research Progress on the Correlation between Vitamin D Level and Coronavirus Disease 2019
摘要: 新型冠状病毒肺炎(COVID-19)大流行已经持续了两年多，至今仍然是全世界关注的首要问题。严重急性呼吸窘迫综合征冠状病毒2 (SARS-CoV-2)可导致下呼吸道出现呼吸窘迫，有时会导致死亡，大多数人推测增强免疫系统是预防COVID-19的一种措施。维生素D缺乏被认为是一个全球性问题，有研究表明维生素D缺乏会影响炎症及免疫调节的许多方面，可能是COVID-19发生的高危因素之一。鉴于维生素D参与了新冠肺炎感染期间发生的各种病理生理机制，因此维生素D可能是对抗SARS-CoV-2的一种有前景的药剂。本综述旨在对维生素D与新冠肺炎之间的相关性研究进展进行综述。
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has lasted for more than two years, and it is still the top concern of the world. The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) causes respiratory distress in the lower respiratory tract and sometimes death, and most people speculate that boosting the immune system is a preventive measure against COVID- 19. Vitamin D deficiency is considered to be a global problem. Studies have shown that vitamin D defi-ciency affects many aspects of inflammation and immune regulation, and may be one of the risk factors for COVID-19. Given its involvement in various pathophysiological mechanisms that occur during COVID-19 infection, vitamin D may be a promising agent against SARS-CoV-2. This review aims to summarize the research progress on the correlation between vitamin D and COVID-19.
文章引用：吴新彤, 赵艺洁. 维生素D水平与新型冠状病毒肺炎相关性的研究进展[J]. 临床医学进展, 2022, 12(11): 10586-10590. https://doi.org/10.12677/ACM.2022.12111524

参考文献

[1] 夏维波, 章振林, 林华, 等. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19.
[2] Fiorino, S., Gallo, C., Zippi, M., et al. (2020) Cytokine Storm in Aged People with CoV-2: Possible Role of Vitamins as Therapy or Preventive Strategy. Aging Clinical and Experimental Research, 32, 2115-2131. [Google Scholar] [CrossRef] [PubMed]
[3] Mohan, M., Cherian, J.J. and Sharma, A. (2020) Exploring Links between Vitamin D Deficiency and COVID-19. PLOS Pathogens, 16, e1008874. [Google Scholar] [CrossRef] [PubMed]
[4] Carlberg, C. (2014) The Physiology of Vitamin D—Far More than Calcium and Bone. Frontiers in Physiology, 5, Article 335. [Google Scholar] [CrossRef] [PubMed]
[5] Khazai, N., Judd, S.E. and Tangpricha, V. (2008) Calcium and Vitamin D: Skeletal and Extraskeletal Health. Current Rheumatology Reports, 10, 110-117. [Google Scholar] [CrossRef] [PubMed]
[6] Finklea, J.D., Grossmann, R.E. and Tangpricha, V. (2011) Vita-min D and Chronic Lung Disease: A Review of Molecular Mechanisms and Clinical Studies. Advances in Nutrition, 2, 244-253. [Google Scholar] [CrossRef] [PubMed]
[7] Pizzini, A., Aichner, M., Sahanic, S., et al. (2020) Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry. Nutrients, 12, Article No. 2775. [Google Scholar] [CrossRef] [PubMed]
[8] Pal, R., Banerjee, M., Bhadada, S.K., et al. (2022) Vitamin D Sup-plementation and Clinical Outcomes in COVID-19: A Systematic Review and Meta-Analysis. Journal of Endocrinolog-ical Investigation, 45, 53-68. [Google Scholar] [CrossRef] [PubMed]
[9] Grant, W.B., Lahore, H., McDonnell, S.L., et al. (2020) Evi-dence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients, 12, Article No. 988. [Google Scholar] [CrossRef] [PubMed]
[10] Hribar, C.A., Cobbold, P.H. and Church, F.C. (2020) Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease. Brain Sciences, 10, Ar-ticle No. 284. [Google Scholar] [CrossRef] [PubMed]
[11] Martín Giménez, V.M., Inserra, F., Tajer, C.D., et al. (2020) Lungs as Target of COVID-19 Infection: Protective Common Molecular Mechanisms of Vitamin D and Melatonin as a New Potential Synergistic Treatment. Life Sciences, 254, Article ID: 117808. [Google Scholar] [CrossRef] [PubMed]
[12] Crane-Godreau, M.A., Clem, K.J., Payne, P. and Fiering, S. (2020) Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 through Suppression of Antiviral Peptide LL37. Fron-tiers in Public Health, 8, Article 232. [Google Scholar] [CrossRef] [PubMed]
[13] Hadizadeh, F. (2021) Supplementation with Vitamin D in the COVID-19 Pandemic? Nutrition Reviews, 79, 200-208. [Google Scholar] [CrossRef] [PubMed]
[14] Aygun, H. (2020) Vitamin D Can Prevent COVID-19 Infec-tion-Induced Multiple Organ Damage. Naunyn-Schmiedeberg’s Archives of Pharmacology, 393, 1157-1160. [Google Scholar] [CrossRef] [PubMed]
[15] de Lucena, T.M.C., da Silva Santos, A.F., de Lima, B.R., et al. (2020) Mechanism of Inflammatory Response in Associated Comorbidities in COVID-19. Diabetes & Metabolic Syn-drome, 14, 597-600. [Google Scholar] [CrossRef] [PubMed]
[16] Bleizgys, A. (2021) Vitamin D and COVID-19: It Is Time to Act. International Journal of Clinical Practice, 75, e13748. [Google Scholar] [CrossRef] [PubMed]
[17] Sanz, R., Mazzei, L., Santino, N., Ingrasia, M. and Manucha, W. (2020) Vitamin D-Mitochondria Cross-Talk Could Modulate the Signaling Pathway Involved in Hypertension Development: A Translational Integrative Overview. Clínica e Investigación en Arteriosclerosis (English Edition), 32, 144-155. [Google Scholar] [CrossRef] 
[18] Annweiler, C., Cao, Z., Wu, Y., Faucon, E., et al. (2020) Coun-ter-Regulatory “Renin-Angiotensin” System-Based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-Infected Patients. Infectious Disorders-Drug Targets, 20, 407-408. [Google Scholar] [CrossRef] 
[19] La Vignera, S., Cannarella, R., Condorelli, R.A., et al. (2020) Sex-Specific SARS-CoV-2 Mortality: Among Hormone- Modulated ACE2 Expression, Risk of Venous Thromboembo-lism and Hypovitaminosis D. International Journal of Molecular Sciences, 21, Article No. 2948. [Google Scholar] [CrossRef] [PubMed]
[20] Ilie, P.C., Stefanescu, S. and Smith, L. (2020) The Role of Vitamin D in the Prevention of Coronavirus Disease 2019 Infection and Mortality. Aging Clinical and Experimental Research, 32, 1195-1198. [Google Scholar] [CrossRef] [PubMed]
[21] Bilezikian, J.P., Bikle, D., Hewison, M., et al. (2020) Mecha-nisms in Endocrinology: Vitamin D and COVID-19. European Journal of Endocrinology, 183, 133-R147. [Google Scholar] [CrossRef] 
[22] Tian, Y. and Rong, L. (2020) Letter: Covid-19, and Vitamin D. Authors’ Reply. Alimentary Pharmacology & Therapeutics, 51, 95-996. [Google Scholar] [CrossRef] [PubMed]
[23] Quesada-Gomez, J.M., Entrenas-Castillo, M. and Bouillon, R. (2020) Vita-min D Receptor Stimulation to Reduce Acute Respiratory Distress Syndrome (ARDS) in Patients with Coronavirus SARS-CoV-2 Infections: Revised Ms SBMB 2020_166. The Journal of Steroid Biochemistry and Molecular Biology, 202, Article ID: 105719. [Google Scholar] [CrossRef] [PubMed]
[24] Jain, A., Chaurasia, R., Sengar, N.S., et al. (2020) Analysis of Vitamin D Level among Asymptomatic and Critically Ill COVID-19 Patients and Its Correlation with Inflammatory Markers. Scientific Reports, 10, Article No. 20191. [Google Scholar] [CrossRef] [PubMed]
[25] Rastogi, A., Bhansali, A., Khare, N., et al. (2022) Short Term, High-Dose Vitamin D Supplementation for COVID-19 Disease: A Randomised, Placebo-Controlled, Study (SHADE Study). Postgraduate Medical Journal, 98, 87-90.

为你推荐